GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » Float Percentage Of Total Shares Outstanding

Synergy Pharmaceuticals (FRA:S90) Float Percentage Of Total Shares Outstanding : 99.28% (As of May. 21, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Synergy Pharmaceuticals's float shares is 246.25 Mil. Synergy Pharmaceuticals's total shares outstanding is 248.04 Mil. Synergy Pharmaceuticals's float percentage of total shares outstanding is 99.28%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Synergy Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Synergy Pharmaceuticals's Institutional Ownership is 17.48%.

Synergy Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Synergy Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=246.25/248.04
=99.28%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synergy Pharmaceuticals (FRA:S90) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
BOM:523620 OWCP XCNQ:ACG NSE:PARABDRUGS BOM:530317 WAR:SP1 XCNQ:RVV XCNQ:CIG MYHI BOM:524703 BOM:531173 XCNQ:VRT BOM:539938 XPAR:MLGML XCNQ:ASIA PCYN XMAU:GOLI.N0000 XCNQ:OSO BSPK XCNQ:EHC
Traded in Other Exchanges
N/A
Address
420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170
Website
http://www.synergypharma.com
Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines